Updated Jul 16, 2026
Walsh Patrick D has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.37M.

| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 10.0K | $80.63 | $806K |
| 2026-05-14 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 4.0K | $80.75 | $321K |
| 2026-03-03 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 6.0K | $74.23 | $445K |
| 2025-08-15 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 9.0K | $89.05 | $801K |
| 2025-05-22 | ANIP | ANI PHARMACEUTICALS INC | A — Grant or award | 4.3K | $0.00 |
Walsh Patrick D is a corporate insider — currently tracked as Director of ANI PHARMACEUTICALS INC (ANIP). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($2.37M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Walsh Patrick D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.